Tune Therapeutics
Tune Therapeutics is a startup headquartered in Seattle, United States, founded in 2020. It has raised at least $182.4m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the growth stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Tune Therapeutics has raised at least $182.4m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Tune Therapeutics sits inside the Seattle and Redmond R&D ecosystem in the Global R&D Labs Directory.
Other startups in Seattle
- 98point6 Technologies
- Accipiter Biosciences
- Adronite
- Aether Studios
- Aggro Crab
- Arrived Holdings
- AtmoCooling
- Automera US
- Better Science
- Bond Communications
- Bonum Therapeutics
Related
- Innovation profile of Seattle
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Tune Therapeutics do?
Tune Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Tune Therapeutics raised?
At least $182.4m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Tune Therapeutics based?
Tune Therapeutics is headquartered in Seattle, United States.
When was Tune Therapeutics founded?
Tune Therapeutics was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.